The Indian pharmaceutical industry has a major share in the global pie of this sector. Worldwide, India stands third in terms of production by volume and 14th by value. The country is the largest provider of generic medicines globally, occupying a 20 per cent share in global supply by volume, and is a leading vaccine manufacturer globally. India also has the highest number of USFDAcompliant pharmaceutical plants outside of the USA and more than 3,000 pharmaceutical companies reside in India bearing a strong network of over 10,500 manufacturing facilities as well as a highly-skilled resource pool.
The pharmaceutical industry in India offers 60,000 generic brands across 60 therapeutic categories. Major segments include generic drugs, OTC medicines, API and bulk drugs, vaccines, contract research and manufacturing, biosimilars and biologics. India stands to be the fourth-largest Asian medical devices market after Japan, China and South Korea, and among the top 20 global medical devices markets in the world. Indian pharmaceutical companies, leveraged by their price competitiveness and good quality, have made a global footprint with 60 per cent of the world’s vaccines and 20 per cent of generic medicines coming from India.
Market Size
Bu hikaye Dalal Street Investment Journal dergisinin June 20, 2022 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Dalal Street Investment Journal dergisinin June 20, 2022 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Giriş Yap
Two to Tango: Indian IT Meets Nasdaq?
The outperformance of NASDAQ is not broad-based and is primarily led by a few companies that are dominant in new emerging technologies and are leading the wave. Indian IT companies and many other traditional IT companies will see a temporary slowdown till the time they do the catching up either organically or inorganically
It's Time To Exit From 'Those' Stocks!
Were you among the investors who sold stocks during the recent market panic, or shouldn’t you have followed the herd mentality? In the unpredictable world of stock markets, recognising the opportune moment to sell can be as crucial as identifying the right time to buy. Mandar Wagh delves into the concepts of intrinsic value and overvaluation, offering insights into strategies investors can employ when their stocks are deemed overvalued
Stress Tests: The Mandate, The Results & Insights
Now that the Securities and Exchange Board of India SEBI) has made it mandatory for fund houses to undertake stress tests for mid-cap and small-cap funds to see if redemptions can be made within a short period in the face of any financial crisis, it is important for investors to Know more about how such stress tests are conducted and what they reveal
Powering the Future: Opportunities in Green Stocks
As the world grapples with the challenges of climate change, the spotlight turns towards renewable energy stocks and their pivotal role in shaping a cleaner, greener future. Kamal Mansuriya analyses the transformative potential of renewable resources, driving both environmental stewardship and economic growth.
Leverage Like a Legend: Warren Buffett's Japan Gambit and Lessons for Investors
Imagine turning a billion dollars into twelve, all without risking a dime of your own. Sounds like financial fiction, right? But that's exactly what investing guru Warren Buffett pulled off with his audacious bet on Japan. In this special story, Vaishnavi Chauhan dissects the unconventional strategy Buffett employed to leverage borrowed money and generate sky-high returns in the Land of the Rising Sun.
The Art Of Identifying Market Winners
When it comes to choosing the right stocks, Dr. Ruzbeh Bodhanwala and Dr. Shernaz Bodhanwala, faculty at FLAME University, Pune suggest that no single metric or ratio should be used to make an investment decision. There is no substitute for thorough fundamental analysis and one should understand the companies' risk profile before investing
Civil construction company gets new order worth 534 crore from Jodhpur Vidyut Vitran Nigam
H.G. Infra Engineering Limited (HGIEL) informed that the company bagged an order worth ₹ 534 crore from Jodhpur Vidyut Vitran Nigam Ltd.
This solar power EPC company achieves the milestone of over 1,000 MW contracted orders globally
Scorpius Trackers, a leading solar tracking technology S company and a of Gensol company and a subsidiary of Gensol Engineering Ltd achievement of reaching a significant milestone of 1000 MW + in contracted orders across India, Japan, Saudi Arabia and Uganda solidifying its position as a key player in the global solar tracking industry.
Recently listed small-cap company bags two orders worth USD 60,43,800
Mukka Protein Ltd has secured purchase orders valued at USD 60,43,800, equivalent to approximately ₹ 50.39 crore from Ever Light Oil Industrial Co. Ltd Land Uni Best General Trading FZE for the fish meal supply.
How To Identify A Market Bubble
While explaining the term market bubble’, this article by Vaishnavi Chauhan elucidates how by prioritising fundamentals, maintaining a long-term perspective and resisting emotional impulses, investors can navigate market bubbles more effectively and safeguard their portfolios against unnecessary risks
